News
MIR
16.92
-0.06%
-0.01
Mirion CFO Brian Schopfer Buys 20,000
The Motley Fool · 13h ago
How $250 Million Buyback At Mirion Technologies (MIR) Has Changed Its Investment Story
Simply Wall St · 18h ago
Weekly Report: what happened at MIR last week (0831-0904)?
Weekly Report · 2d ago
Why Mirion Technologies (MIR) Is Up 17.6% After New Buyback Plan And Jefferies Coverage Initiation
Simply Wall St · 3d ago
Mirion Technologies Price Target Announced at $20.00/Share by Jefferies
Dow Jones · 5d ago
Mirion Technologies Initiated at Buy by Jefferies
Dow Jones · 5d ago
Jefferies Initiates Coverage On Mirion Technologies with Buy Rating, Announces Price Target of $20
Benzinga · 5d ago
Nuclear names Cameco and BWXT initiated with Buy ratings at Jefferies
Seeking Alpha · 5d ago
Mirion Technologies Up Over 8%, on Pace for Largest Percent Increase Since October 2025 -- Data Talk
Dow Jones · 5d ago
Why Mirion (MIR) Stock Is Trading Up Today
Barchart · 5d ago
Baird Reiterates Buy on Mirion, Citing Nuclear Exposure, Margin Expansion Drivers, and $20 Price Target
TipRanks · 6d ago
Mirion initiated with a Buy at Jefferies
TipRanks · 6d ago
2 Stocks Under $50 to Target This Week and 1 Facing Challenges
Barchart · 6d ago
Top Executive Makes Bold Move on Mirion Technologies Stock
TipRanks · 6d ago
Mirion CFO buys $312K in common stock
TipRanks · 6d ago
Mirion Technologies Announces New Share Repurchase Program
TipRanks · 08/31 20:53
Mirion announces new $250M buyback program
TipRanks · 08/31 20:20
Weekly Report: what happened at MIR last week (0824-0828)?
Weekly Report · 08/31 09:51
What Is Drawing Attention To Mirion Technologies (MIR) Today?
Simply Wall St · 08/26 04:52
Why The Nuclear Sector Still Has Room To Grow
Seeking Alpha · 08/24 20:35
More
Webull provides a variety of real-time MIR stock news. You can receive the latest news about Mirion Technologies Inc through multiple platforms. This information may help you make smarter investment decisions.
About MIR
Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets. The Company's segments include Medical, and Nuclear & Safety. The Medical segment includes products and services for radiation therapy, nuclear medicine and personal dosimetry. This segment’s principal product offering is in Radiation Therapy Quality Assurance, which includes solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy. The Nuclear & Safety segment includes products and services focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, laboratories and research and other industrial markets such as defense. For nuclear power plants (NPPs), it sells products and services for use at any stage of their life (construction, operation, decommissioning and dismantling).